Reassessing Benefit-Risk: FDA Preps for New Guidance - Regulatory Focus

Reassessing Benefit-Risk: FDA Preps for New Guidance  Regulatory FocusUS Food and Drug Administration (FDA) and pharmaceutical industry experts gathered Thursday in Silver Spring, MD, to discuss how FDA assesses the benefits ...